Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Dagher A.

Neuroimage Clin. 2019 Aug 19;24:101986. doi: 10.1016/j.nicl.2019.101986. [Epub ahead of print]

2.

Canadian guideline for Parkinson disease.

Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A, Lafontaine AL, Mestre T, Appel-Cresswell S, Kalia SK, Schoffer K, Zurowski M, Postuma RB, Udow S, Fox S, Barbeau P, Hutton B.

CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504. No abstract available.

PMID:
31501181
3.

Update of the MDS research criteria for prodromal Parkinson's disease.

Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB; MDS Task Force on the Definition of Parkinson's Disease.

Mov Disord. 2019 Aug 14. doi: 10.1002/mds.27802. [Epub ahead of print] Review.

PMID:
31412427
4.

Gender and funding success.

Appel-Cresswell S, Blanchet PJ, Wysocki J, Postuma RB.

Lancet. 2019 Jun 1;393(10187):2195-2196. doi: 10.1016/S0140-6736(19)31107-9. No abstract available.

PMID:
31162073
5.

Prodromal Parkinson disease: do we miss the signs?

Postuma RB.

Nat Rev Neurol. 2019 Aug;15(8):437-438. doi: 10.1038/s41582-019-0215-z. No abstract available.

PMID:
31152151
6.

Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.

Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB.

Brain. 2019 Jul 1;142(7):2051-2067. doi: 10.1093/brain/awz111.

PMID:
31111143
7.

Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.

Cross NE, Carrier J, Postuma RB, Gosselin N, Kakinami L, Thompson C, Chouchou F, Dang-Vu TT.

Sleep. 2019 Aug 1;42(8). pii: zsz114. doi: 10.1093/sleep/zsz114.

PMID:
31089710
8.

Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with 18F-FEOBV.

Bedard MA, Aghourian M, Legault-Denis C, Postuma RB, Soucy JP, Gagnon JF, Pelletier A, Montplaisir J.

Sleep Med. 2019 Jun;58:35-41. doi: 10.1016/j.sleep.2018.12.020. Epub 2019 Jan 6.

PMID:
31078078
9.

Glucocerebrosidase mutations and phenoconversion of REM sleep behavior disorder to parkinsonism and dementia.

Honeycutt L, Montplaisir JY, Gagnon JF, Ruskey J, Pelletier A, Gan-Or Z, Postuma RB.

Parkinsonism Relat Disord. 2019 Apr 27. pii: S1353-8020(19)30211-1. doi: 10.1016/j.parkreldis.2019.04.016. [Epub ahead of print]

PMID:
31076265
10.

Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.

Postuma RB, Berg D.

Mov Disord. 2019 May;34(5):665-675. doi: 10.1002/mds.27670. Epub 2019 Mar 28. Review.

PMID:
30919499
11.

Brain atrophy in Parkinson's disease with polysomnography-confirmed REM sleep behavior disorder.

Rahayel S, Gaubert M, Postuma RB, Montplaisir J, Carrier J, Monchi O, Rémillard-Pelchat D, Bourgouin PA, Panisset M, Chouinard S, Joubert S, Gagnon JF.

Sleep. 2019 Jun 11;42(6). pii: zsz062. doi: 10.1093/sleep/zsz062.

PMID:
30854555
12.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

13.

A case-control-family study of idiopathic rapid eye movement sleep behavior disorder.

Liu Y, Zhang J, Lam SP, Zhou J, Yu MWM, Li SX, Chan JWY, Postuma RB, Mok VCT, Wing YK.

Ann Neurol. 2019 Apr;85(4):582-592. doi: 10.1002/ana.25435. Epub 2019 Mar 19.

PMID:
30761606
14.

Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder.

Fereshtehnejad SM, Dawson BK, Pelletier A, Montplaisir JY, Postuma RB.

Mov Disord Clin Pract. 2018 Jan 10;5(2):203-205. doi: 10.1002/mdc3.12576. eCollection 2018 Mar-Apr. No abstract available.

15.

Gray matter substrates of depressive and anxiety symptoms in idiopathic REM sleep behavior disorder.

Bourgouin PA, Rahayel S, Gaubert M, Postuma RB, Montplaisir J, Carrier J, Monchi O, Pelletier A, Gagnon JF.

Parkinsonism Relat Disord. 2019 May;62:163-170. doi: 10.1016/j.parkreldis.2018.12.020. Epub 2018 Dec 17.

PMID:
30616869
16.

Risk factors for possible REM sleep behavior disorder: A CLSA population-based cohort study.

Yao C, Fereshtehnejad SM, Keezer MR, Wolfson C, Pelletier A, Postuma RB.

Neurology. 2018 Dec 26. pii: 10.1212/WNL.0000000000006849. doi: 10.1212/WNL.0000000000006849. [Epub ahead of print]

PMID:
30587514
17.

From Prodromal to Overt Parkinson's Disease: Towards a New Definition in the Year 2040.

Berg D, Postuma RB.

J Parkinsons Dis. 2018;8(s1):S19-S23. doi: 10.3233/JPD-181457.

18.

Mediterranean diets and prodromal Parkinson's disease: A causal line, or a confound circle?

Postuma RB.

Mov Disord. 2019 Jan;34(1):4-6. doi: 10.1002/mds.27538. Epub 2018 Nov 6. No abstract available.

PMID:
30398674
19.

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Dadar M, Zeighami Y, Yau Y, Fereshtehnejad SM, Maranzano J, Postuma RB, Dagher A, Collins DL.

Neuroimage Clin. 2018;20:892-900. doi: 10.1016/j.nicl.2018.09.025. Epub 2018 Sep 27.

20.

Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD).

Ruffini G, Ibañez D, Kroupi E, Gagnon JF, Montplaisir J, Postuma RB, Castellano M, Soria-Frisch A.

Ann Biomed Eng. 2019 Jan;47(1):282-296. doi: 10.1007/s10439-018-02112-0. Epub 2018 Aug 30.

PMID:
30167913
21.

REM sleep behaviour disorder.

Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, Montplaisir J, Boeve B.

Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5. Review.

PMID:
30166532
22.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
23.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
24.

Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism.

Al-Qassabi A, Pelletier A, Fereshtehnejad SM, Postuma RB.

J Parkinsons Dis. 2018;8(3):463-468. doi: 10.3233/JPD-181357.

PMID:
30040743
25.

The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies.

Ruskey JA, Zhou S, Santiago R, Franche LA, Alam A, Roncière L, Spiegelman D, Fon EA, Trempe JF, Kalia LV, Postuma RB, Dupre N, Rivard GE, Assouline S, Amato D, Gan-Or Z.

Clin Genet. 2018 Oct;94(3-4):339-345. doi: 10.1111/cge.13405. Epub 2018 Jul 16.

PMID:
29920646
26.

Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.

Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, Ambalavanan A, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Charley Monaca C, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon JF, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA, Gan-Or Z.

Mov Disord. 2018 Jul;33(6):1016-1020. doi: 10.1002/mds.27385. Epub 2018 May 14.

PMID:
29756641
27.

Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?

Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF, Montplaisir JY, Postuma RB.

Parkinsonism Relat Disord. 2018 Sep;54:99-102. doi: 10.1016/j.parkreldis.2018.04.010. Epub 2018 Apr 4.

PMID:
29724601
28.

Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.

Lipsmeier F, Taylor KI, Kilchenmann T, Wolf D, Scotland A, Schjodt-Eriksen J, Cheng WY, Fernandez-Garcia I, Siebourg-Polster J, Jin L, Soto J, Verselis L, Boess F, Koller M, Grundman M, Monsch AU, Postuma RB, Ghosh A, Kremer T, Czech C, Gossens C, Lindemann M.

Mov Disord. 2018 Aug;33(8):1287-1297. doi: 10.1002/mds.27376. Epub 2018 Apr 27.

29.

Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder.

Rahayel S, Postuma RB, Montplaisir J, Génier Marchand D, Escudier F, Gaubert M, Bourgouin PA, Carrier J, Monchi O, Joubert S, Blanc F, Gagnon JF.

Neurology. 2018 May 15;90(20):e1759-e1770. doi: 10.1212/WNL.0000000000005523. Epub 2018 Apr 18.

30.

How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder.

Génier Marchand D, Postuma RB, Escudier F, De Roy J, Pelletier A, Montplaisir J, Gagnon JF.

Ann Neurol. 2018 May;83(5):1016-1026. doi: 10.1002/ana.25239. Epub 2018 May 16.

PMID:
29665124
31.

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB.

JAMA Neurol. 2018 Jun 1;75(6):704-710. doi: 10.1001/jamaneurol.2018.0254. Erratum in: JAMA Neurol. 2018 Jun 1;75(6):763.

32.

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Mollenhauer B, Sixel-Döring F, Trenkwalder C, Oertel W, Montplaisir JY, Postuma RB, Rouleau GA, Gan-Or Z.

Parkinsonism Relat Disord. 2018 Jul;52:98-101. doi: 10.1016/j.parkreldis.2018.03.019. Epub 2018 Mar 21.

PMID:
29576439
33.

Sleep disorders and Parkinson disease; lessons from genetics.

Gan-Or Z, Alcalay RN, Rouleau GA, Postuma RB.

Sleep Med Rev. 2018 Oct;41:101-112. doi: 10.1016/j.smrv.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29449121
34.

Prospective memory in idiopathic REM sleep behavior disorder with or without mild cognitive impairment: A preliminary study.

Marcone S, Gagnon JF, Desjardins C, David AC, Postuma RB, Montplaisir J, Joubert S, Rouleau I.

Clin Neuropsychol. 2019 Apr;33(3):571-593. doi: 10.1080/13854046.2018.1435825. Epub 2018 Feb 7.

PMID:
29411691
35.

A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Mišić B, Dagher A.

Neuroimage. 2019 Apr 15;190:69-78. doi: 10.1016/j.neuroimage.2017.12.050. Epub 2017 Dec 19. Review.

PMID:
29277406
36.

Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.

Bacchi S, Chim I, Kramer P, Postuma RB.

J Parkinsons Dis. 2017;7(4):603-617. doi: 10.3233/JPD-171209. Review.

PMID:
29103053
37.

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA.

JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248.

38.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

39.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

40.

Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.

Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Irving EL, Postuma RB, Chouinard S, Kergoat H.

Can J Neurol Sci. 2017 Sep;44(5):562-566. doi: 10.1017/cjn.2017.39.

PMID:
28862105
41.

Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis?

Postuma RB.

Int Rev Neurobiol. 2017;133:519-539. doi: 10.1016/bs.irn.2017.04.002. Epub 2017 Jun 7. Review.

PMID:
28802931
42.

Dementia with Lewy bodies: Diagnosis is only skin deep?

Postuma RB, Walker Z.

Neurology. 2017 Jul 25;89(4):310-311. doi: 10.1212/WNL.0000000000004163. Epub 2017 Jun 30. No abstract available.

PMID:
28667177
43.

Insomnia and somnolence in idiopathic RBD: a prospective cohort study.

Postuma RB, Gagnon JF, Pelletier A, Montplaisir JY.

NPJ Parkinsons Dis. 2017 Mar 20;3:9. doi: 10.1038/s41531-017-0011-7. eCollection 2017.

44.

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.

Shafieesabet A, Fereshtehnejad SM, Shafieesabet A, Delbari A, Baradaran HR, Postuma RB, Lökk J.

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15. Review.

PMID:
28647434
45.

REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease.

Jozwiak N, Postuma RB, Montplaisir J, Latreille V, Panisset M, Chouinard S, Bourgouin PA, Gagnon JF.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx101.

46.

Dopaminergic Imaging and Prodromal Parkinson Disease: A Key Biomarker Arrives.

Postuma RB.

JAMA Neurol. 2017 Aug 1;74(8):901-903. doi: 10.1001/jamaneurol.2017.0846. No abstract available.

PMID:
28595262
47.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

48.

Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features.

Rahayel S, Postuma RB, Montplaisir J, Bedetti C, Brambati S, Carrier J, Monchi O, Bourgouin PA, Gaubert M, Gagnon JF.

Cereb Cortex. 2018 Feb 1;28(2):658-671. doi: 10.1093/cercor/bhx137.

PMID:
28591814
49.

The New Diagnostic Criteria for Parkinson's Disease.

Postuma RB, Berg D.

Int Rev Neurobiol. 2017;132:55-78. doi: 10.1016/bs.irn.2017.01.008. Epub 2017 Mar 3. Review.

PMID:
28554421
50.

Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB.

Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

PMID:
28549077

Supplemental Content

Loading ...
Support Center